论文部分内容阅读
目的分析心血管内科急性心绞痛的临床治疗。方法本文随机抽取我院心血管内科于2016年8月~2017年2月收治的74例急性心绞痛患者为研究对象。按照患者治疗方法的差异将其区分为对照组和观察组两个组别,分别给予两组患者常规治疗、氯吡格雷治疗,观察急性心绞痛患者的治疗总有效率、住院时间、发作持续时间、血液流变学指标(血浆纤维蛋白原、全血黏度、血浆黏度)。结果观察组急性心绞痛患者的治疗总有效率、住院时间、发作持续时间、血液流变学指标均优于对照组患者,两组患者间的差异有统计学意义(P<0.05)。结论氯吡格雷用于心血管内科急性心绞痛患者的治疗,可提高患者的治疗总有效率,缩短住院时间和发作时间,改善患者的血液流变学指标,具有极高的临床价值。
Objective To analyze the clinical treatment of acute angina in cardiovascular medicine. Methods A total of 74 patients with acute angina pectoris who were admitted to our hospital from August 2016 to February 2017 were selected randomly from this study. Patients were divided into control group and observation group according to the difference of patients’ treatment methods. Patients in both groups were given routine treatment and clopidogrel treatment respectively. The total effective rate of treatment, length of hospital stay, duration of attack, Hemorheology indicators (plasma fibrinogen, whole blood viscosity, plasma viscosity). Results The total effective rate of treatment, length of hospital stay, duration of attack and hemorrheological indexes in the observation group were better than those in the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion Clopidogrel for the treatment of patients with acute angina pectoris in cardiovascular medicine can improve the total effective rate of treatment, shorten the hospitalization time and onset time, and improve the patient’s hemorheological parameters, with high clinical value.